Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Minerva Neurosciences, Inc. Director's Dealing 2021

Dec 3, 2021

35086_dirs_2021-12-03_5907b6ef-11a0-4c55-8c36-27574dcb3c32.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2021-12-01

Reporting Person: Kupfer David (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-12-01 Common Stock S 55635 $0.88 Disposed 163553 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 27935 Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.85 to $0.9235 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.